Foresight Nanotech Institute Logo
Image of nano

Nanotechnology tailors carbon nanotubes to deliver cancer treatment in mice

In a study with breast cancer in mice, a nanotech cancer therapy suppresses tumor growth with minimal side effects. Taking advantage of the fact that the blood vessels in tumor tissue are leakier than in normal tissue, carbon nanotubes of the right size and with the proper chemical coating deliver more tumor-killing drug to tumors, while sparing normal tissue. In future experiments, the researchers may add molecules that specifically target tumor cells to achieve even greater specificity. ScienceDaily features a story from Stanford University News, written by Louis Bergeron “Nanotubes deliver high-potency punch to cancer tumors in mice“:

The problem with using a shotgun to kill a housefly is that even if you get the pest, you’ll likely do a lot of damage to your home in the process. Hence the value of the more surgical flyswatter.

Cancer researchers have long faced a similar situation in chemotherapy: how to get the most medication into the cells of a tumor without “spillover” of the medication adversely affecting the healthy cells in a patient’s body.

Now researchers at Stanford University have addressed that problem using single-walled carbon nanotubes as delivery vehicles. The new method has enabled the researchers to get a higher proportion of a given dose of medication into the tumor cells than is possible with the “free” drug—that is, the one not bound to nanotubes—thus reducing the amount of medication that they need to inject into a subject to achieve the desired therapeutic effect.

“That means you will also have less drug reaching the normal tissue,” said Hongjie Dai, professor of chemistry and senior author of a paper, which will be published in the Aug. 15 issue of Cancer Research [abstract]. So not only is the medication more effective against the tumor, ounce for ounce, but it greatly reduces the side effects of the medication.

Graduate student Zhuang Liu is first author of the paper.

Dai and his colleagues worked with paclitaxel, a widely used cancer chemotherapy drug, which they employed against tumors cells of a type of breast cancer that were implanted under the skin of mice. They found that they were able to get up to 10 times as much medication into the tumor cells via the nanotubes as when the standard formulation of the drug, called Taxol®, was injected into the mice.

The tumor cells were allowed to proliferate for about two weeks prior to being treated. After 22 days of treatment, tumors in the mice treated with the paclitaxel-bearing nanotubes were on average less than half the size of those in mice treated with Taxol.

Critical to achieving those results were the size and surface structure of the nanotubes, which governed how they interacted with the walls of the blood vessels through which they circulated after being injected. Though a leaky vessel—nautical or anatomical—is rarely a good thing, in this instance the relatively leaky walls of blood vessels in the tumor tissue provided the opening that the nanotubes needed to slip into the tumor cells.

“The results are actually highly dependent on the surface chemistry,” Dai said. “In other words, you don’t get this result just by attaching drugs to any nanotubes.”

The researchers used nanotubes that they had coated with polyethylene glycol (PEG), a common ingredient in cosmetics. The PEG they used was a form that has three little branches sprouting from a central trunk. Stuffing the trunks into the linked hexagonal rings that make up the nanotubes created a visual effect that Dai described as looking like rolled-up chicken wire with feathers sticking out all over. The homespun sounding appearance notwithstanding, the nanotubes proved to be highly effective delivery vehicles when the researchers attached the paclitaxel to the tips of the branches.

…Dai said that the technique holds potential for delivering a range of medications and that it may also be possible to develop ways to channel the nanotubes to their target even more precisely.

“Right now what we are doing is so-called ‘passive targeting,’ which is using the leaky vasculature of the tumor,” he said. “But a more active targeting would be attaching a peptide or antibody to the nanotube drug, one that will bind more specifically to the tumor, which should further enhance the treatment efficacy.”

Dai’s team is already at work developing more targeted approaches, and he is optimistic about the potential applications of nanotubes.

“We are definitely hoping to be able to push this to practical applications into the clinic. This is one step forward,” he said. “But it will still take time to truly prove the efficacy and the safety.”

—Jim

One Response to “Nanotechnology tailors carbon nanotubes to deliver cancer treatment in mice”

  1. willisT Says:

    This is very good. One problem however is that this does not appear to affect circulating cancer cells since it targets tumors through the leaky blood vessels. Unless the circulating cells are eradicated you have the problem of these cells finding a perch somewhere else in the body to form new tumors. But it is a great result they are reporting that we are becoming able to manipulate the surface of particles in such a way that we can get very high concentrations selectively into tumors.

    This is like moving from dumb bombs to something much closer to a JDAMs. Now we need some patriot missiles to knock down the circulating cells. One method that makes sense if the technology develops might be the blood circulation filtering machine – something like a dialysis machine that instead of removing waste selectively removes cancer cells.

    If you’re someone who reads about subjects like this, keep thinking because I think we are getting close enough for someone to have a big idea, maybe even someone who isn’t an expert in either molecular biology of cancer or nanotechnology. There are many pathways that can be targeted in cancer cells and there are many ways nanotechnology techniques being developed for many different applications. The people who work on this professionally are doing all they can but can’t hurt to have an extra set of eyes on it.

Leave a Reply